Trials / Completed
CompletedNCT05827328
Explore the Optimal Surgical Timing for Lung Surgery and Mediastinal Surgery After COVID-19 Infection
A Prospective Observational Study to Explore the Optimal Surgical Timing for Lung Surgery and Mediastinal Surgery After COVID-19 Infection
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 2,000 (actual)
- Sponsor
- Shanghai Pulmonary Hospital, Shanghai, China · Academic / Other
- Sex
- All
- Age
- 18 Years – 85 Years
- Healthy volunteers
- Not accepted
Summary
Exploring the optimal interval time in patients with the clinical diagnosis of lung cancer or mediastinal tumors indicated for thoracic surgeries after SARS-CoV-2 infection by comparing 30-day mortality and 30-day morbidity.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Observation | Observe the 30-day mortality and 30-day morbidity. |
Timeline
- Start date
- 2023-01-29
- Primary completion
- 2023-06-30
- Completion
- 2023-06-30
- First posted
- 2023-04-25
- Last updated
- 2023-07-18
Locations
6 sites across 1 country: China
Source: ClinicalTrials.gov record NCT05827328. Inclusion in this directory is not an endorsement.